baber/WOPTO huggingface dataset:
Patent NZ-569754-A (NZ)
Title: Interactive input system
Inventor: MORRISON GERALD
IPC: G06F3/041
Filed: 2007-01-12
Abstract: An interactive input system (50) comprises at least two imaging devices (60) acquiring images of a region of interest from different locations and having overlapping fields of view and at least one receiver (62) separate from the imaging devices and configured to receive contact verify data output by an active pointer (70) when the active pointer is within the fields of view of the imaging devices and is in contact with a touch surface (54). The at least one receiver is further configured to receive command data output by the active pointer when the active pointer is within the fields of view of the imaging devices and when the active pointer is outside of the fields of view of the imaging devices; and The interactive input system further comprises a processing structure (64) processing image data acquired by the at least two imaging devices and contact verify data received by the at least one receiver to detect and verify the existence of an active pointer in contact with the touch surface and to determine the location of the pointer within the region of interest. The processing structure further processing the command data received by the at least one receiver.
Patent NZ-578084-A (NZ)
Title: Rotary travelling boom irrigator with nozzle spray deflector plate
Inventor: PLUCK NEIL GRAHAM EDWARD
IPC: B05B3/06
Filed: 2010-09-01
Abstract: A rotating boom irrigator is provided with first and second booms rotating about a common axis and each having a 75 degree bend 2 near, and a nozzle 4 at, a distal end. Only the second boom includes a deflector 6 adjacent the distal end so that the jet of water exiting the second boom nozzle 4 at an upwardly inclined angle A (30 degrees with respect to the horizontal) is redirected by the deflector to have an angle of 45 to 55 degrees with respect to the horizontal and to be in the form of an even fan spray of water. The deflector configuration includes a convex 15 redirect portion and, at an angle to the redirect portion, an attachment portion 14 to attach the deflector adjacent the end of the boom.
Patent NZ-580480-A (NZ)
Title: Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
Inventor: BORGHESE ALFIO
IPC: C07D213/46
Filed: 2004-10-12
Abstract: Disclosed is the compound (2-chlorophenyl)-[2-(2-hydroxy-2-pyridin-4-yl-vinyl)-pyridin-3-yl]-methanone, or a salt thereof. Also disclosed is a process for preparing the compound {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl]-1H-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone, comprising reacting (2-chlorophenyl)-[2-(2-hydroxy-2-pyridin-4-yl-vinyl)-pyridin-3-yl]-methanone or a phosphate salt thereof with 1-azidomethyl-3-,5-bistrifluoromethylbenzene in the presence of a suitable base and a solvent. (62) Divided Out of 545917
Patent NZ-585922-A (NZ)
Title: Use of 4-[3-[4-(6-fluoro-1,2,-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-benzoic acid in the treatment of prostate enlargement
Inventor: POLYMEROPOULOS MIHAEL H
IPC: A61K31/445
Filed: 2008-12-13
Abstract: Disclosed is the use of 4-[3-[4-(6-fluoro-1,2,-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-benzoic acid alone or a pharmaceutically acceptable salt thereof alone in the manufacture of a medicament for the treatment of prostate enlargement such as benign prostatic hyperplasia in a male mammal.
Patent NZ-587071-A (NZ)
Title: THE USE OF ALTERNAN AS INGREDIENT FOR CERTAIN ACID FOODSTUFFS WITH pH OF LESS THAN 3
Inventor: PILLING JENS
IPC: A23L33/00
Filed: 2009-01-30
Abstract: Discloses the use of alternan-oligosaccharide with a weight average degree of polymerization of 18.5 or 15.4 or below as ingredient for acidic foodstuffs or beverages, wherein the foodstuff has a pH of below 3. The alternan -oligosaccharide is produced by the reaction of sucrose with a suitable acceptor molecule in presence of alternan-sucrase enzyme and the foodstuff is subjected to heating temperature of at least 60 °C or 80-130 °C. Further discloses the use of alternan-oligosaccharide as ingredient for acidic foodstuffs or beverages, wherein the amount of alternan-oligosaccharide is in a range of 0.1-10 % based on total weight.
Patent NZ-588950-A (NZ)
Title: Cooling of an electrical generator using hollow cooling pipes integrated into stacked laminate plates of a stator
Inventor: STIESDAL HENRIK
IPC: H02K9/00
Filed: 2010-11-01
Abstract: An arrangement for cooling a wind turbine electrical generator. The generator contains at least two stator segments with multiple stacked laminated plates that are aligned to a rotor, and the rotor. The plurality of stacked laminated plates contain longitudinal slots that support metal wire windings as a stator coil. Hollow cooling pipes are embedded in the laminated stack plates with a cooling fluid or liquid flowing through the cooling pipes and the embedded cooling pipes are removable from or replaceable into the stator as a single assembly. The cooling pipes are located on the opposite side to the coil slots. The cooling pipes act as a heat exchanger and a heat transfer compound is provides thermal contact between the cooling pipe and the stator stacked laminate plates. The hair-pin bends of the cooling pipes are shaped to reduce induced voltages. The cooling pipes also help provide structural support for the laminate plates. The cooling pipes are made from a non-magnetic metal such as stainless steel.
Patent NZ-589091-A (NZ)
Title: Quinuclidine derivatives as muscarinic m3 receptor antagonists
Inventor: FORD RHONAN LEE
IPC: A61K31/439
Filed: 2008-05-13
Abstract: Disclosed is a 1-azonia-bicyclo[2.2.2]octane selected from the group consisting by way of example; (R)-1-[(6-Methyl-pyridin-3-ylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)5-1-azonia-bicyclo[2.2.2]octane X; (R)-1-[(6-Methyl-pyrazin-2-ylcarbamoyl)-methyl]-3-(1-phenyl-cycloheptanecarbonyloxy)-1-azonia-bicyclo[2.2.2]octane X wherein X represents a pharmaceutically acceptable anion of a mono or polyvalent acid. Also disclosed is the use of said compounds in the treatment of chronic obstructive pulmonary disease, a method of preparation.
Patent NZ-592477-A (NZ)
Title: Pyrazolylaminopyridines as inhibitors of fak
Inventor: ADAMS JERRY LEROY
IPC: C07D231/00
Filed: 2009-10-27
Abstract: 592477 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK The disclosure relates to a class of pyrazolylaminopyridines that inhibit Focal Adhesion Kinase (FAK), as well as compositions thereof. Compounds of the disclosure are useful in the treatment of proliferative diseases including, but not limited to cancer. The compounds of the disclosure are 2-[(5-Chloro-2-{ [3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino} -4-pyridinyl)amino]-N-(methyloxy)benzamide and 2-[(5-Chloro-2-{ [3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino} -4-pyridinyl)amino]-N-(methyloxy)benzamide, cancers for which the compounds of the disclosure may be used to treat are skin, breast, brain, cervical carcinomas, testicular carcinomas, astrocytic, colorectal, endometrial, esophageal, gastric, head and neck, hepatocellular, laryngeal, lung, oral, ovarian, prostate, thyroid carcinomas, sarcomas, lung, lymphomas, mesothelioma, Gastrointestinal, stomach, pancreas, small bowel, large bowel, kidney, bladder and urethra, liver, bone, Ewing's sarcoma, malignant lymphoma, multiple myeloma, malignant giant cell tumor chordoma, , brain, glioblastoma multiform, spinal cord, uterus, cervical, ovarian, squamous cell carcinoma, and hematologic cancers.
Patent NZ-595211-A (NZ)
Title: High performance drilling fluids with submicron-size particles as the weighting agent
Inventor: ZHANG YING
IPC: C09K8/03
Filed: 2010-03-16
Abstract: Patent No. 595211 Disclosed is a drilling fluid comprising: a carrier fluid; and a weighting agent that comprises sub-micron precipitated barite having a particle size distribution such that at least 10% of particles in the sub-micron precipitated barite have a diameter below about 0.2 microns, at least 50% of the particles in the submicron precipitated barite have a diameter below about 0.3 microns and at least 90% of the particles in the sub-micron precipitated barite have a diameter below about 0.5 microns; a particle having a specific gravity of greater than about 2.6, wherein the particle having a specific gravity of greater than about 2.6 is not sub-micron precipitated barite; wherein the ratio of the sub-micron precipitated barite to the particle is about 10:90 to about 99:1; and a bridging agent that is not the sub-micron precipitated barite or the particle, wherein the bridging agent comprises at least one degradable material selected from the group consisting of montanyl alcohol, tertbutylhydroquinone, cholesteryl nonanoate, benzoin, exo-norborneol, glyceraldehyde triphenylmethanol, propyl gallate, dimethyl terephthalate, cholecalciferol, ricinoleyl alcohol, 1-heptacosanol, 1-tetratriacontanol, 1-dotriacontanol, 1-hentriacontanol, 1-tricontanol, 1-nonacosanol, 1-octasanol, 1-hexacosanol, 1,14-tetradecanediol, 1,16-hexadecanediol, 1,17-heptadecanediol, 1,18-octadecanediol, 1,19-nonadecanediol, 1,20-eicosanediol, 1,21-heneicosanediol, 1,22-docosanediol, sucrose distearate, glyceryl monostearate, and any combination thereof.
Patent NZ-596386-A (NZ)
Title: Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
Inventor: HOVLAND RAGNAR
IPC: C07C69/587
Filed: 2010-05-07
Abstract: IP No. 596386 The present disclosure relates to lipid compounds of the general formula (I): R1-O-C(R2)(R3) -X (I) wherein R1 is a C10-C22 alkenyl group having 1-6 double bonds, or a C10-C22 alkynyl group having 1-6 triple bonds; R2 and R3 are the same or different and may be chosen from different substituents; and X is a carboxylic acid or a derivative thereof, such as a carboxylic ester, a carboxylic anhydride, a phospholipid, triglyceride, or a carboxamide; or a pharmaceutically acceptable salt, solvate, solvate of such salt or a prodrug thereof. The present disclosure also relates to pharmaceutical compositions and lipid compositions comprising at least one compound according to the present disclosure, and to such compounds for use as medicaments or for use in therapy, in particular for the treatment of diseases related to the cardiovascular, metabolic, and inflammatory disease area.
Patent NZ-597525-A (NZ)
Title: Drop-in chlorinator for portable spas
Inventor: MCCAGUE MICHAEL
IPC: C02F1/461
Filed: 2010-04-22
Abstract: An oxidizer generating apparatus comprising a cylindrical housing and an electrode assembly attached at one end of the housing comprising at least three vertically disposed electrodes, the electrodes being spaced apart so as to define a water flow path between them, the electrodes comprising titanium outer electrodes and at least one inner diamond electrode.
Patent NZ-601698-A (NZ)
Title: Fatty acid fumarate derivatives and their uses
Inventor: MILNE JILL C
IPC: C07C233/49
Filed: 2011-01-07
Abstract: Disclosed are fatty acid fumarate derivatives as represented by the general formulae (I) or (II), or a pharmaceutically acceptable salt, hydrate, solvate, enantiomer, or stereoisomer thereof; wherein each W1,W2, W1′ and W2′ is independently null, O, S, NH, or NR, or W1 and W2, or W1′ and W2′ can be taken together to form an optionally substituted imidazolidine or piperazine group; each n, o, p, q, n′, o′, p′, and q′ is independently 0, 1, or 2; each m and m′ is independently 0, 1, 2, or 3; each Z and Z′ is independently -H, or a fatty acid moiety, or a 1,2-dithiolane substituted alkyl derivative all as defined herein; provided that at least one of Z and Z′ is not H; and wherein the remaining substituents are as defined herein. Representative compounds include (E)-methyl 4-(2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamidoethylamino)-4-oxobut-2-enoate, (E)-methyl 4-(2-(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenamidoethylamino)-4-oxobut-2-enoate, (S)-6-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)-2-((E)-4-methoxy-4-oxobut-2-enamido)hexanoic acid, (S)-1,3-dihydroxypropan-2-yl 6-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)-2-((E)-4-methoxy-4-oxobut-2-enamido)hexanoate, (S)-5-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)-2-((E)-4-methoxy-4-oxobut-2-enamido)pentanoic acid, (S)-1,3-dihydroxypropan-2-yl 5-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)-2-((E)-4-methoxy-4-oxobut-2-enamido)pentanoate, and (S)-1,3-dihydroxypropan-2-yl 2-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)-5-((E)-4-ethoxy-4-oxobut-2-enamido)pentanoate. Also disclosed is a pharmaceutical composition comprising a compound as defined above, and a pharmaceutically acceptable carrier, for use in the treatment of a neurodegenerative disease, an inflammation, or an inflammatory disease.
Patent NZ-603911-A (NZ)
Title: Pressure control valve with a hollow plug acted on by an opening spring and a counteracting backpressure that acts on an enlarged portion of the plug
Inventor: MEDINA CARLO
IPC: G05D16/10
Filed: 2012-11-28
Abstract: A pressure control valve 1 comprises a housing 2 defining a flow path P for a fluid between an inlet 3 and an outlet 4, a hollow plug 5 for the fluid, movable between a closed position C, in which the plug 5 is coupled with a closing washer 27 for interrupting the flow of fluid, and an open position A to enable the fluid to pass, a counteracting spring 8 exerting an opening force FA for pushing the plug 5 to the open position A. The plug 5 and the spring 8 are configured in such a manner that the closed position C is reached at a set limit pressure value of the fluid downstream. The plug 5 comprises an enlarged portion 10 that is suitable for receiving from the fluid downstream a closing force Fc which counteracts the opening force FA and acts towards the closed position C. The enlarged portion 10 has a transverse external dimension equal to a first value. The plug 5 further comprises an intermediate portion 11 that is slidable on guiding and sealing means 12 and has an external transverse dimension that is equal to a second value D2 less than the first value D1.
Patent NZ-628649-A (NZ)
Title: A fastening clamp
Inventor: IAN JOHN DRAPIER
IPC: B60R9/058
Filed: 2014-08-12
Abstract: A fastening clamp 3 comprises a body 6 positioned alongside a planar surface or object 2. The body 6 includes at least one projection 7 extending from at least part of the body 6 over and abutting a lip 8 extending from the planar surface or object. The clamp 3 further comprises at least one fastener linking the body 6 to a mount point on which the body 6 of the fastening clamp 3 is placed. When the fastener is fixed in place, the projection 7 or projections fix via friction to the planar object or surface to the mount point. The projection surface or surfaces abutting the planar object lip 8 or lips are contoured to allow rotation of the clamp 3 about a substantially perpendicular axis relative to the planar surface object.
Patent NZ-630903-A (NZ)
Title: Fruit fly olfactory attractant composition and use thereof
Inventor: DREW RICHARD
IPC: A01P19/00
Filed: 2013-10-03
Abstract: The disclosure relates to an olfactory attractant composition for fruit flies and its use in methods of attracting fruit flies, controlling fruit flies and monitoring for the presence of fruit flies. In particular, the olfactory attractant composition comprises at least five different lower alkyl esters of the formula C1-4alkylC(O)OC1-4alkyl selected from the group consisting of methyl acetate, ethyl acetate, propyl acetate, ethyl propionate, ethyl butanoate, methyl butanoate and isobutyl acetate, wherein ethyl propionate is present in an amount of from 1% to 25%; optionally methanol, ethanol or a mixture thereof; and optionally isopentyl acetate, ethyl hexanoate or a mixture thereof. Also disclosed is a device for dispensing the composition and an apparatus for trapping fruit flies comprising said composition and optionally an insecticide composition.
Patent NZ-631880-A (NZ)
Title: Multilayer timber panel and building frame element
Inventor: LANCASTER THOMAS EDWARD
IPC: E04C2/00
Filed: 2013-07-22
Abstract: A multilayer timber panel of a laminated sandwich including top and bottom layers and at least one intermediate layer, the layers being rectangular and having a pair of shorter edges and a pair of longer edges, is layered up so that the predominant grain direction of the timber in an edge region along the shorter edges of the top and bottom layers is substantially parallel to the shorter edges and the predominant grain direction of the timber in at least an edge region along the longer edges of the top and bottom layers is substantially parallel to the longer edges. A building frame element 18 which is a portal frame comprising a pair of spaced apart columns, an upper beam and a lower beam, can be formed from the multilayer timber panel by removing a central portion from the panel that is cut out of the panel once the rectangular panel is formed. A building skeletal frame can be constructed using these portal frames and using the cut out central portions 19 as floors.
Patent NZ-700553-A (NZ)
Title: Improvements in and relating to access doors
Inventor: PETER DOUGLAS RAYMOND KNOTTS
IPC: E06B3/48
Filed: 2014-10-03
Abstract: An access door for covering an opening, the opening including a left hand frame member and a right hand frame member on opposite sides thereof, the access door including a first door and a second door, the first and second doors pivotably attached to the left hand side frame member and the right hand side frame member so as to be rotatable along a width of the opening between an open position and a closed position, wherein the first door is configured to cover a first portion of the opening and the second door is configured to cover the remainder of the opening and overlap a portion of the first door and wherein the doors rotate in opposite directions to one another.
Patent NZ-704627-A (NZ)
Title: Spirocyclic isoxazoline parasiticidal combinations
Inventor: CHUBB NATHAN ANTHONY LOGAN
IPC: C07D491/107
Filed: 2013-09-04
Abstract: The present invention relates to a novel antiparasitic composition comprising an effective amount of a) a Formula (1) compound, wherein R1a, R1b, R1c, R2, R3, R4, and n are as defined herein, stereoisomer thereof, or a pharmaceutical or veterinary acceptable salt thereof, b) a macrocyclic lactone or derivative thereof and c) optionally, at least one additional veterinary agent, and further comprising at least one veterinary or pharmaceutical acceptable carrier; and a method of treating an animal with a parasitic infection, by administering an effective amount of said composition to the animal in need thereof.
Patent NZ-705154-A (NZ)
Title: Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson’s disease
Inventor: GALLEY GUIDO
IPC: C07D417/14
Filed: 2013-09-11
Abstract: The present invention relates to compounds of formula (I) wherein R1 is phenyl, optionally substituted by halogen, lower alkyl, lower cycloalkyl, lower alkoxy, cyano, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy, lower alkoxy substituted by halogen or lower alkoxy substituted by hydroxy; or is pyridine-2, 3 or 4-yl, optionally substituted by halogen, lower alkyl, lower cycloalkyl, cyano, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy, lower alkoxy, lower alkoxy substituted by halogen or lower alkoxy substituted by hydroxyl; or is pyrimidin-2, 4 or 5-yl, optionally substituted by halogen, lower alkyl, lower cycloalkyl, lower alkyl substituted by hydroxy or lower alkyl substituted by halogen; or is pyrazin-2-yl, optionally substituted by halogen, lower alkyl, lower cycloalkyl, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy or cyano; or is 2,2-difluorobenzo[d][1,3]dioxol-5-yl, or is thiazolyl, optionally substituted by lower alkyl substituted by halogen; R2 is hydrogen or lower alkyl; R3 is hydrogen, amino or lower alkyl; Z is a bond, -CH2- or -O-; or to a pharmaceutically suitable acid addition salt thereof. It has now been found that the compounds of formulas I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson’s disease, neurodegenerative disorders such as Alzheimer’s disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
Patent NZ-705922-A (NZ)
Title: Motion greeting cards
Inventor: MELISSA FLESHER
IPC: B42D15/00
Filed: 2015-03-12
Abstract: The present invention and related disclosure describes greeting cards with moving elements or devices which are operable to create motion in connection with some portion of the greeting card. The greeting card may include a multi-panel greeting card body or a three-dimensional foam greeting card body. At least one movable object is contained upon or within the greeting card body. A sound module having at least one pre-recorded digital audio file saved therein and a motor module are contained and concealed within the greeting card body. One or more switches may be used to activate the sound and motor modules, causing the pre-recorded audio file to play and causing movement of the movable or mobile object.
Patent NZ-708495-A (NZ)
Title: Split-pass open-die forging for hard-to-forge, strain-path sensitive titanium-base and nickel-base alloys
Inventor: THOMAS JEAN-PHILIPPE
IPC: C22F1/18
Filed: 2014-03-03
Abstract: The present disclosure relates to developing a method of working that provides sufficient strain to a metallic material to initiate microstructure refinement mechanisms efficiently through forging, while limiting ductility issues. In this regard, the invention provides split pass forging a workpiece to initiate microstructure refinement that comprises press forging a metallic material workpiece in a first forging direction one or more times up to a reduction ductility limit of the metallic material to impart a total strain in the first forging direction sufficient to initiate microstructure refinement; rotating the workpiece; open die press forging the workpiece in a second forging direction one or more times up to the reduction ductility limit to impart a total strain in the second forging direction to initiate microstructure refinement; and repeating rotating and open die press forging in a third and, optionally, one or more additional directions until a total amount of strain to initiate microstructure refinement is imparted in an entire volume of the workpiece.
Patent NZ-713550-A (NZ)
Title: A solids injection lance
Inventor: DRY RODNEY JAMES
IPC: F27B3/18
Filed: 2014-05-02
Abstract: The disclosure relates to a method for injecting a solid feed material through a solids injection lance. The method includes creating flow conditions in an injection passageway of the lance so that at least a part of the feed material flowing along the passageway forms a buffer zone between a wall of a tube that defines the passageway and feed material flowing along a central section of the passageway. The flow conditions are created such that the buffer zone extends along the required length of the tube to shield sections of the tube that are susceptible to high abrasive wear or thermal shock.
Patent NZ-717476-A (NZ)
Title: Anti-garp protein and uses thereof
Inventor: LUCAS SOPHIE
IPC: C07K16/28
Filed: 2014-08-01
Abstract: The present invention relates to an antibody binding to the transmembrane protein ‘glycoprotein A repetitions predominant’ (GARP) in the presence of TGF-β and uses thereof.